The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Non-small Cell Lung Cancer Collaborative Group (1995) · BMJ · doi:10.1136/bmj.311.7010.899 · Cited by 2,850
Bucher, H. C., Guyatt, G. H., Griffith, L. E., & Walter, S. D. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00049-8 · Cited by 2,052
Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
Saglio, G., Kim, D.-W., Issaragrisil, S., le Coutre, P., Etienne, G., Lobo, C., Pasquini, R., Clark, R. E., Hochhaus, A., Hughes, T. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912614 · Cited by 1,678
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Kantarjian, H., Shah, N. P., Hochhaus, A., Cortes, J., Shah, S., Ayala, M., Moiraghi, B., Shen, Z., Mayer, J., Pasquini, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002315 · Cited by 1,589
A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer
Pignon, J.-P., Arriagada, R., Ihde, D. C., Johnson, D. H., Perry, M. C., Souhami, R. L., Brodin, O., Joss, R. A., Kies, M. S., Lebeau, B., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212033272302 · Cited by 1,331
Network meta‐analysis for indirect treatment comparisons
Lumley, T. (2002) · Statistics in Medicine · doi:10.1002/sim.1201 · Cited by 1,206
Etanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
Collaboration, H. L. T. (1998) · BMJ · doi:10.1136/bmj.316.7135.894 · Cited by 1,084
Hirano, K., & Imbens, G. W. (2001) · Health Services and Outcomes Research Methodology · doi:10.1023/a:1020371312283 · Cited by 1,039
Jansen, J. P., Fleurence, R., Devine, B., Itzler, R., Barrett, A., Hawkins, N., Lee, K., Boersma, C., Annemans, L., & Cappelleri, J. C. (2011) · Value in Health · doi:10.1016/j.jval.2011.04.002 · Cited by 1,036
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Menter, A., Tyring, S. K., Gordon, K., Kimball, A. B., Leonardi, C. L., Langley, R. G., Strober, B. E., Kaul, M., Gu, Y., Okun, M., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.09.010 · Cited by 889
Hoaglin, D. C., Hawkins, N., Jansen, J. P., Scott, D. A., Itzler, R., Cappelleri, J. C., Boersma, C., Thompson, D., Larholt, K. M., Diaz, M., et al. (2011) · Value in Health · doi:10.1016/j.jval.2011.01.011 · Cited by 770
Saurat, J. ‐., Stingl, G., Dubertret, L., Papp, K. A., Langley, R. G. B., Ortonne, J. ‐., Unnebrink, K., Kaul, M., Camez, A., & for the CHAMPION Study Investigators (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08315.x · Cited by 728
Papp, K. A., Tyring, S., Lahfa, M., Prinz, J., Griffiths, C. E. M., Nakanishi, A. M., Zitnik, R., van de Kerkhof, P. C. M., & the Etanercept Psoriasis Study Group (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06688.x · Cited by 693
Indirect comparisons of competing interventions
Glenny, A., Altman, D., Song, F., Sakarovitch, C., Deeks, J., D'Amico, R., Bradburn, M., & Eastwood, A. (2005) · Health Technology Assessment · doi:10.3310/hta9260 · Cited by 677
Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., Spencer, T., & the Atomoxetine ADHD Study Group (2001) · Pediatrics · doi:10.1542/peds.108.5.e83 · Cited by 666
Michelson, D., Allen, A. J., Busner, J., Casat, C., Dunn, D., Kratochvil, C., Newcorn, J., Sallee, F. R., Sangal, R. B., Saylor, K., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1896 · Cited by 599
Dias, S., Welton, N. J., Sutton, A. J., & Ades, A. E. (2011) · Bristol Research (University of Bristol) · Cited by 553
Ecological Bias, Confounding, and Effect Modification
GREENLAND, S., & MORGENSTERN, H. (1989) · International Journal of Epidemiology · doi:10.1093/ije/18.1.269 · Cited by 540
Gordon, K. B., Langley, R. G., Leonardi, C., Toth, D., Menter, M. A., Kang, S., Heffernan, M., Miller, B., Hamlin, R., Lim, L., et al. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.027 · Cited by 510
Berlin, J. A., Santanna, J., Schmid, C. H., Szczech, L. A., & Feldman, H. I. (2002) · Statistics in Medicine · doi:10.1002/sim.1023 · Cited by 468
Kelsey, D. K., Sumner, C. R., Casat, C. D., Coury, D. L., Quintana, H., Saylor, K. E., Sutton, V. K., Gonzales, J., Malcolm, S. K., Schuh, K. J., et al. (2004) · Pediatrics · doi:10.1542/peds.114.1.e1 · Cited by 464
Sallee, F. R., Mcgough, J., Wigal, T., Donahue, J., Lyne, A., & Biederman, J. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318191769e · Cited by 391
Signorovitch, J. E., Wu, E. Q., Yu, A. P., Gerrits, C. M., Kantor, E., Bao, Y., Gupta, S. R., & Mulani, P. M. (2010) · PharmacoEconomics · doi:10.2165/11538370-000000000-00000 · Cited by 377
Self-citationUse of Indirect and Mixed Treatment Comparisons for Technology Assessment
Sutton, A., Ades, A. E., Cooper, N., & Abrams, K. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826090-00006 · Cited by 355
Spencer, T., Heiligenstein, J. H., Biederman, J., Faries, D. E., Kratochvil, C. J., Conners, C. K., & Potter, W. Z. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1209 · Cited by 333
Biederman, J., Melmed, R. D., Patel, A., McBurnett, K., Konow, J., Lyne, A., Scherer, N., & for the SPD503 Study Group (2008) · Pediatrics · doi:10.1542/peds.2006-3695 · Cited by 317
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
Richter, B., Bandeira-Echtler, E., Bergerhoff, K., & Lerch, C. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006739.pub2 · Cited by 308
Cortes, J. E., Baccarani, M., Guilhot, F., Druker, B. J., Branford, S., Kim, D.-W., Pane, F., Pasquini, R., Goldberg, S. L., Kalaycio, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.3724 · Cited by 284
A multilevel model framework for meta-analysis of clinical trials with binary outcomes
Turner, R. M., Omar, R. Z., Yang, M., Goldstein, H., & Thompson, S. G. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20001230)19:24<3417::aid-sim614>3.0.co;2-l · Cited by 265
Moore, A. R., & McQuay, J. H. (1997) · Pain · doi:10.1016/s0304-3959(96)03291-5 · Cited by 236
NICE Guide to the Methods of Technology Appraisal: Pharmaceutical Industry Perspective
Earnshaw, J., & Lewis, G. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826090-00002 · Cited by 226
DeFronzo, R. A., Stonehouse, A. H., Han, J., & Wintle, M. E. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02941.x · Cited by 213
Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes
Nonaka, K., Kakikawa, T., Sato, A., Okuyama, K., Fujimoto, G., Kato, N., Suzuki, H., Hirayama, Y., Ahmed, T., Davies, M. J., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.08.021 · Cited by 208
Inconsistency in Networks of Evidence Based on Randomised Controlled Trials
Dias, S., Welton, N. J., Sutton, A. J., Caldwell, D. M., Lu, G., & Ades, A. E. (2011) · Bristol Research (University of Bristol) · Cited by 202
First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib
Wei, G., Rafiyath, S., & Liu, D. (2010) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-3-47 · Cited by 170
Dias, S., Sutton, A. J., Welton, N. J., & Ades, A. E. (2011) · Bristol Research (University of Bristol) · Cited by 159
Fakhoury, W. K. H., LeReun, C., & Wright, D. (2010) · Pharmacology · doi:10.1159/000314690 · Cited by 112
NICE DSU Technical Support Document 1: Introduction to Evidence Synthesis for Decision Making
Dias, S., Welton, N. J., Sutton, A. J., & Ades, A. E. (2011) · Bristol Research (University of Bristol) · Cited by 110
Iwamoto, Y., Taniguchi, T., Nonaka, K., Okamoto, T., Okuyama, K., Ferreira, J. C. A., & Amatruda, J. M. (2010) · Endocrine Journal · doi:10.1507/endocrj.k09e-272 · Cited by 106
Chou, R., Fu, R. F., Huffman, L. H., & Korthuis, P. T. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69638-4 · Cited by 104
Iwamoto, Y., Tajima, N., Kadowaki, T., Nonaka, K., Taniguchi, T., Nishii, M., Ferreira, J. C. A., & Amatruda, J. M. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01197.x · Cited by 102
Kikuchi, M., Abe, N., Kato, M., Terao, S., Mimori, N., & Tachibana, H. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.10.006 · Cited by 94
Iwamoto, Y., Kashiwagi, A., Yamada, N., Terao, S., Mimori, N., Suzuki, M., & Tachibana, H. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01222.x · Cited by 72
Signorovitch, J., Wu, E. Q., Swallow, E., Kantor, E., Fan, L., & Gruenberger, J.-B. (2011) · Clinical Drug Investigation · doi:10.2165/11592490-000000000-00000 · Cited by 45
Self-citation
Cited by
Liau, L. M., Ashkan, K., Brem, S., Campian, J. L., Trusheim, J. E., Iwamoto, F. M., Tran, D. D., Ansstas, G., Cobbs, C. S., Heth, J. A., et al. (2023) · JAMA Oncology · doi:10.1001/jamaoncol.2022.5370 · Cited by 451
Bachy, E., Le Gouill, S., Di Blasi, R., Sesques, P., Manson, G., Cartron, G., Beauvais, D., Roulin, L., Gros, F. X., Rubio, M. T., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01969-y · Cited by 405
Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal
Phillippo, D. M., Ades, A. E., Dias, S., Palmer, S., Abrams, K. R., & Welton, N. J. (2018) · Medical Decision Making · doi:10.1177/0272989x17725740 · Cited by 396
Get real in individual participant data (IPD) meta‐analysis: a review of the methodology
Debray, T. P. A., Moons, K. G. M., van Valkenhoef, G., Efthimiou, O., Hummel, N., Groenwold, R. H. H., Reitsma, J. B., & on behalf of the GetReal methods review group (2015) · Research Synthesis Methods · doi:10.1002/jrsm.1160 · Cited by 348
Network meta‐analysis of multicomponent interventions
Rücker, G., Petropoulou, M., & Schwarzer, G. (2020) · Biometrical Journal · doi:10.1002/bimj.201800167 · Cited by 195
Metadata
- Authors
- Signorovitch, J. E., Sikirica, V., Erder, M. H., Xie, J., Lu, M., Hodgkins, P. S., Betts, K. A., & Wu, E. Q.
- Venue
- Value in Health
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 15
- Issue
- 6
- Pages
- 940-947
- ISSN
- 1098-3015 (ISSN-L)
- OpenAlex
- W2092901728
- Cited by
- 505
- References
- 47
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.